# |
PMID |
Sentence |
1 |
30998685
|
Reverse cholesterol transport involves the transport of cholesterol to HDL by cellular ATP-binding cassette; ABCA1 and ABCG1 with subsequent delivery from peripheral tissues to the liver.
|
2 |
30998685
|
Cholesterol content, cholesterol efflux, and ABCA1 and ABCG1 mRNA expression were measured.
|
3 |
30998685
|
Kidney, spleen, and bone marrow-derived macrophages from APOL1-G1 and -G2 mice showed increased cholesterol accumulation and decreased ABCA1 and ABCG1 mRNA levels.
|
4 |
30998685
|
Reverse cholesterol transport involves the transport of cholesterol to HDL by cellular ATP-binding cassette; ABCA1 and ABCG1 with subsequent delivery from peripheral tissues to the liver.
|
5 |
30998685
|
Cholesterol content, cholesterol efflux, and ABCA1 and ABCG1 mRNA expression were measured.
|
6 |
30998685
|
Kidney, spleen, and bone marrow-derived macrophages from APOL1-G1 and -G2 mice showed increased cholesterol accumulation and decreased ABCA1 and ABCG1 mRNA levels.
|
7 |
30998685
|
Reverse cholesterol transport involves the transport of cholesterol to HDL by cellular ATP-binding cassette; ABCA1 and ABCG1 with subsequent delivery from peripheral tissues to the liver.
|
8 |
30998685
|
Cholesterol content, cholesterol efflux, and ABCA1 and ABCG1 mRNA expression were measured.
|
9 |
30998685
|
Kidney, spleen, and bone marrow-derived macrophages from APOL1-G1 and -G2 mice showed increased cholesterol accumulation and decreased ABCA1 and ABCG1 mRNA levels.
|
10 |
32642006
|
Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.
|
11 |
32642006
|
Methods: Bioinformatics analysis of renal biopsy specimens from patients with hypertensive nephropathy (HN) suggests the involvement of Sirtuin 6 (Sirt6) in Ang II-induced dysregulation of glomerular cholesterol.
|
12 |
32642006
|
Using a podocyte-specific Sirt6 knockout mouse model, the effects of Sirt6 on Ang II-induced cholesterol accumulation in podocytes and the therapeutic efficacies of cholesterol-lowering agents were evaluated.
|
13 |
32642006
|
Results: Cholesterol accumulation was detected in the podocytes of Ang II-infused mice, whereas selective deletion of Sirt6 in podocytes not only increased cholesterol accumulation in these cells but also exacerbated Ang II-induced kidney injury.
|
14 |
32642006
|
Deletion of Sirt6 also attenuated the protective effect of cyclodextrin (CD) on Ang II-induced urinary albumin excretion, glomerulosclerosis and podocyte injury.
|
15 |
32642006
|
In addition, we demonstrated that Sirt6 affected cholesterol efflux in podocytes by regulating the expression of ATP-binding cassette transporter G1 (ABCG1).
|
16 |
32642006
|
Conclusions: These findings provide evidence that Sirt6 is a potential target for renin-angiotensin system (RAS)-associated podocyte injury and provide a rationale for the application of cholesterol-lowering agents in patients with CKD.
|